Nutritional Status of Women Undergoing in Vitro Fertilization
Dietary Patterns, Physical Activity Level, Body Composition and Serum Vitamin B9, Vitamin B12 and Vitamin D Levels in Women Undergoing in Vitro Fertilization and the Outcomes of in Vitro Fertilization
1 other identifier
observational
69
1 country
2
Brief Summary
Infertility affects around 15 % of couples in their reproductive years. Even though the use of assisted reproductive technologies (ART) in aforementioned couples is increasing, their success rate is still relatively low. Hence it is important to identify and better understand potential modifiable dietary and lifestyle risk factors that may influence the success of ART. This study will include women undergoing IVF with a view to investigating the relationship between preconception dietary patterns, body composition, physical activity level, serum values of vitamin B9, vitamin B12 and vitamin D and the outcomes of IVF, such as the number of obtained oocytes, fertilization rate and clinical pregnancy. Main hypothesis is that women undergoing IVF, who eat a balanced diet, maintain healthy body weight and have adequate serum levels of vitamin B9, vitamin B12 and vitamin D, have a higher chance of achieving better IVF outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2023
CompletedFirst Submitted
Initial submission to the registry
May 9, 2023
CompletedFirst Posted
Study publicly available on registry
May 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2023
CompletedMay 9, 2024
February 1, 2024
2 months
May 9, 2023
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oocyte number
Total Number of oocytes produced.
3 months
Secondary Outcomes (1)
Fertilization rate
3 months
Other Outcomes (1)
Clinical pregnancy rate
6 months
Eligibility Criteria
Women undergoing IVF treatment at the University Medical Centre Ljubljana.
You may qualify if:
- Undergoing IVF/ICSI treatment
You may not qualify if:
- Women's age \> 39
- Endometriosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Division of Ob/Gyn, University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
Division of Peadiatrics, University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
Biospecimen
The patient will have blood drawn for biochemical laboratory tests at the Clinical Institute of Clinical Chemistry and Biochemistry, University Clinical Centre Ljubljana (in addition to the standard tests, the investigators will also determine vitamin B9 or folate and folic acid, vitamin B12, vitamin D, oligoelements, heavy metals, hormone disruptors, etc.) The protection of personal data will be guaranteed, as each blood sample will be labelled or recorded during the study under a code identical to the code of the questionnaire completed by the patient. Information on the results of the IVF/ICSI procedure will be obtained from the patients' medical records with their consent.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2023
First Posted
May 18, 2023
Study Start
January 5, 2023
Primary Completion
March 2, 2023
Study Completion
September 10, 2023
Last Updated
May 9, 2024
Record last verified: 2024-02